Penn State sues insulin makers and PBMs alleging inflated prices and seeks damages for overpayments in its self-insured health plans.

HIV/AIDS activists heralded the approval of a new twice-yearly pre-exposure prophylaxis (PrEP) medication last year, but ...

The reason? CVS is more diversified—they operate retail pharmacies (9,000 locations), Pharmacy Benefit Management (CVS ...

A new report from the House Judiciary Committee alleges that CVS Health may have violated antitrust laws by preventing ...

The company’s massive pharmacy benefit manager changed its rules and weaponized audits to ensure independent pharmacies ...

The antitrust agency paused its lawsuit against the pharmacy benefit manager while the two discuss a proposed consent agreement.

Amid multiple lawsuits against pharmacy benefit managers, a pair of bills have been filed in the 2026 Missouri legislative ...

CVS Health outlined its efforts to decrease prior authorizations, reduce hospital readmissions and emergency room visits and ...

The City of Providence, along other municipalities and states, is taking big pharma to court over the price of insulin.

The House Judiciary Committee reports that CVS Caremark may have violated antitrust laws by pressuring independent pharmacies ...

The CEOs pushed back on the criticisms, saying rising premiums reflect higher costs elsewhere in the health care system. The ...

The Federal Trade Commission (FTC) and Evernorth may be on the cusp of a settlement to resolve allegations that the company's ...